David Spirk Selected Research

Embolism (Embolus)

1/2016

Electronic Alert System for Improving Stroke Prevention Among Hospitalized Oral-Anticoagulation-Naïve Patients With Atrial Fibrillation: A Randomized Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Spirk Research Topics

Disease

7	Myocardial Infarction 03/2024 - 08/2009
7	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 06/2014
6	Pathologic Constriction (Stenosis) 03/2024 - 06/2014
6	Thrombosis (Thrombus) 11/2023 - 01/2015
6	Hemorrhage 10/2023 - 08/2009
6	Neoplasms (Cancer) 05/2021 - 10/2009
5	Infarction (Infarctions) 03/2024 - 01/2021
4	Coronary Artery Disease (Coronary Atherosclerosis) 03/2024 - 01/2021
4	Venous Thromboembolism 10/2022 - 01/2016
4	Hypertension (High Blood Pressure) 01/2020 - 01/2012
3	Pulmonary Embolism 03/2024 - 04/2012
3	Atherosclerotic Plaque (Atheroma) 10/2023 - 01/2021
3	COVID-19 10/2023 - 08/2022
3	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 04/2017
2	Acute Coronary Syndrome 01/2021 - 01/2016
2	May-Thurner Syndrome 12/2019 - 07/2019
2	Lung Diseases (Lung Disease) 01/2016 - 04/2012
2	Heart Failure 01/2016 - 04/2012
1	Disease Progression 03/2024
1	Venous Insufficiency 03/2024
1	Ulcer 03/2024
1	Pain (Aches) 03/2024
1	Peripheral Arterial Disease 11/2022
1	Rupture 10/2022
1	Thrombophlebitis 05/2022
1	Hypercholesterolemia 01/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Postthrombotic Syndrome 12/2019
1	Embolism (Embolus) 01/2016
1	Renal Insufficiency (Renal Failure) 01/2016
1	Stroke (Strokes) 01/2016
1	Atrial Fibrillation 01/2016
1	Weight Gain 01/2015
1	Type 2 Diabetes Mellitus (MODY) 01/2015
1	Hyperlipidemias (Hyperlipidemia) 01/2012
1	Wounds and Injuries (Trauma) 10/2009

Drug/Important Bio-Agent (IBA)

7	alirocumabIBA 03/2024 - 01/2021
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024 - 01/2021
4	Enoxaparin (Lovenox)FDA LinkGeneric 10/2023 - 08/2009
3	LipidsIBA 10/2023 - 01/2021
3	RivaroxabanIBA 10/2022 - 01/2016
3	LDL CholesterolIBA 01/2022 - 01/2012
3	oxidized low density lipoproteinIBA 01/2022 - 04/2017
2	PCSK9 InhibitorsIBA 03/2024 - 07/2023
2	Proprotein Convertase 9IBA 09/2023 - 10/2022
2	nitinolIBA 12/2020 - 12/2018
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2019 - 05/2011
2	AnticoagulantsIBA 12/2018 - 01/2016
1	Proteins (Proteins, Gene)FDA Link 03/2024
1	SubtilisinIBA 03/2024
1	Factor Xa InhibitorsIBA 10/2022
1	N(4)-oleylcytosine arabinosideIBA 10/2022
1	2-bromolysergic acid diethylamide (BOL)IBA 08/2022
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2021
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2020
1	Irbesartan FDA LinkGeneric 01/2020
1	Vitamin K FDA Link 12/2018
1	4- (2- (4- hydroxybenzyl)- phenoxy)- N- methylbutylamineIBA 01/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2017
1	Insulin Glargine (Lantus)FDA Link 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Insulin (Novolin)FDA Link 01/2015
1	Phenobarbital (Luminal)FDA Link 06/2014
1	polyelectrolyte 60IBA 04/2012
1	HDL CholesterolIBA 01/2012
1	Triglycerides (Triacylglycerol)IBA 01/2012

Therapy/Procedure

14	Therapeutics 10/2023 - 08/2009
8	Stents 03/2024 - 01/2018
6	Catheters 11/2023 - 06/2014
3	Percutaneous Coronary Intervention 10/2022 - 08/2009
1	Thrombectomy 11/2023
1	Sclerotherapy 05/2022
1	Vascular Surgical Procedures 10/2009